Are the available experimental models of type 2 diabetes appropriate for a gender perspective?

Pharmacological Research

Volumn 57, Issue 1, 2008, Pages 6-18

  Franconi, Flavia ^a   Seghieri, Giuseppe ^b   Canu, Silvia ^a   Straface, Elisabetta ^c   Campesi, Ilaria ^a   Malorni, Walter ^c  

^a UNIVERSITY OF SASSARI   (Italy)

^b Spedali Riuniti ^*  (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Animal experimental models; Diabetes mellitus; Gender; Sex

Indexed keywords

TESTOSTERONE;

CARDIOVASCULAR DISEASE; DIABETIC RETINOPATHY; DISEASE COURSE; GLUCOSE TOLERANCE; HUMAN; HYPERANDROGENISM; INSULIN RESISTANCE; INSULIN SENSITIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOGENESIS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE;

ANIMALS; CATS; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; FEMALE; FETAL GROWTH RETARDATION; GONADAL STEROID HORMONES; HUMANS; MALE; MICE; PRIMATES; RATS; SEX CHARACTERISTICS; SWINE;

EID: 39149104626     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2007.11.007     Document Type: Review

References (238)

1. Giuffrida F.M., and Reis A.F. Genetic and clinical characteristics of maturity-onset diabetes of the young. Diabetes Obes Metab 7 (2005) 318-326
2. Buchanan T.A., and Xiang A.H. Gestational diabetes mellitus. J Clin Invest 115 (2005) 485-491
3. Fourlanos S., Dotta F., Greenbaum C.J., Palmer J.P., Rolandsson O., Colman P.G., et al. Latent autoimmune diabetes in adults (LADA) should be less latent. Diabetologia 48 (2005) 2206-2212
4. Legato M.J., Gelzer A., Goland R., Ebner S.A., Rajan S., Villagra V., et al. Gender-specific care of the patient with diabetes: review and recommendations. Gend Med 3 (2006) 131-158
5. Regitz-Zagrosek V., Lehmkuhl E., and Weickert M.O. Gender differences in the metabolic syndrome and their role for cardiovascular disease. Clin Res Cardiol 95 (2006) 136-147
6. Wilkin T.J., and Murphy M.J. The gender insulin hypothesis: why girls are born lighter than boys, and the implications for insulin resistance. Int J Obes (Lond) 30 (2006) 1056-1061
7. Huxley R., Barzi F., and Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 332 (2006) 73-78
8. Juutilainen A., Kortelainen S., Lehto S., Ronnemaa T., Pyorala K., and Laakso M. Gender difference in the impact of type 2 diabetes on coronary heart disease risk. Diabetes Care 27 (2004) 2898-2904
9. Clark J.B., Palmer C.J., and Shaw W.N. The diabetic Zucker fatty rat. Proc Soc Exp Biol Med 173 (1983) 68-75
10. Mori S., Kawano K., Hirashima T., and Natori T. Relationships between diet control and the development of spontaneous type II diabetes and diabetic nephropathy in OLETF rats. Diabetes Res Clin Pract 33 (1996) 145-152
11. Russell J.C., Graham S.E., and Dolphin P.J. Glucose tolerance and insulin resistance in the JCR:LA-corpulent rat: effect of miglitol (Bay m1099). Metabolism 48 (1999) 701-706
12. Weksler-Zangen S., Yagil C., Zangen D.H., Ornoy A., Jacob H.J., and Yagil Y. The newly inbred cohen diabetic rat: a nonobese normolipidemic genetic model of diet-induced type 2 diabetes expressing sex differences. Diabetes 50 (2001) 2521-2529
13. Rees D.A., and Alcolado J.C. Animal models of diabetes mellitus. Diabet Med 22 (2005) 359-370
14. Ziv E., Shafrir E., Kalman R., Galer S., and Bar-On H. Changing pattern of prevalence of insulin resistance in Psammomys obesus, a model of nutritionally induced type 2 diabetes. Metabolism 48 (1999) 1549-1554
15. Suto J., Matsuura S., Imamura K., Yamanaka H., and Sekikawa K. Genetic analysis of non-insulin-dependent diabetes mellitus in KK and KK-Ay mice. Eur J Endocrinol 139 (1998) 654-661
16. Rand J.S., Fleeman L.M., Farrow H.A., Appleton D.J., and Lederer R. Canine and feline diabetes mellitus: nature or nurture?. J Nutr 134 (2004) 2072S-2080S
17. Henson M.S., and O'Brien T.D. Feline models of type 2 diabetes mellitus. ILAR J 47 (2006) 234-242
18. Bellinger D.A., Merricks E.P., and Nichols T.C. Swine models of type 2 diabetes mellitus: insulin resistance, glucose tolerance, and cardiovascular complications. ILAR J 47 (2006) 243-258
19. Wagner J.E., Kavanagh K., Ward G.M., Auerbach B.J., Harwood Jr. H.J., and Kaplan J.R. Old world nonhuman primate models of type 2 diabetes mellitus. ILAR J 47 (2006) 259-271
20. Bernardis L.L., and Goldman J.K. Production of the weanling rat dorsomedial hypothalamic syndrome by cathodal electrolytic lesion current. J Neurosci Res 2 (1976) 291-298
21. Black B.L., Croom J., Eisen E.J., Petro A.E., Edwards C.L., and Surwit R.S. Differential effects of fat and sucrose on body composition in A/J and C57BL/6 mice. Metabolism 47 (1998)
22. Blondeau B., Garofano A., Czernichow P., and Breant B. Age-dependent inability of the endocrine pancreas to adapt to pregnancy: a long-term consequence of perinatal malnutrition in the rat. Endocrinology 140 (1999) 4208-4213
23. Garofano A., Czernichow P., and Breant B. Effect of ageing on beta-cell mass and function in rats malnourished during the perinatal period. Diabetologia 42 (1999) 711-718
24. Nyirenda M.J., Welberg L.A., and Seckl J.R. Programming hyperglycaemia in the rat through prenatal exposure to glucocorticoids-fetal effect or maternal influence?. J Endocrinol 170 (2001) 653-660
25. Nagata M., Suzuki W., Iizuka S., Tabuchi M., Maruyama H., Takeda S., et al. Type 2 diabetes mellitus in obese mouse model induced by monosodium glutamate. Exp Anim 55 (2006) 109-115
26. Shafrir E. Diabetes in animals: contribution to the understanding of diabetes by study of its etiopathology in animal models. In: Porte D., Sherwin R.S., and Baron A. (Eds). Diabetes mellitus (2003), McGraw-Hill, New York 231-255
27. Ehtisham S., Hattersley A.T., Dunger D.B., and Barrett T.G. First UK survey of paediatric type 2 diabetes and MODY. Arch Dis Child 89 (2004) 526-529
28. Rosenbloom A.L., Joe J.R., Young R.S., and Winter W.E. Emerging epidemic of type 2 diabetes in youth. Diabetes Care 22 (1999) 345-354
29. Fagot-Campagna A., Pettitt D.J., Engelgau M.M., Burrows N.R., Geiss L.S., Valdez R., et al. Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective. J Pediatr 136 (2000) 664-672
30. Shields B.M., Knight B., Hopper H., Hill A., Powell R.J., Hattersley A.T., et al. Measurement of cord insulin and insulin-related peptides suggests that girls are more insulin resistant than boys at birth. Diabetes Care 30 (2007) 2661-2666
31. Murphy M.J., Metcalf B.S., Voss L.D., Jeffery A.N., Kirkby J., Mallam K.M., et al. Girls at five are intrinsically more insulin resistant than boys: The Programming Hypotheses Revisited-The EarlyBird Study (EarlyBird 6). Pediatrics 113 (2004) 82-86
32. Bavdekar A., Yajnik C.S., Fall C.H., Bapat S., Pandit A.N., Deshpande V., et al. Insulin resistance syndrome in 8-year-old Indian children: small at birth, big at 8 years, or both?. Diabetes 48 (1999) 2422-2429
33. Young-Hyman D., Schlundt D.G., Herman L., De Luca F., and Counts D. Evaluation of the insulin resistance syndrome in 5- to 10-year-old overweight/obese African-American children. Diabetes Care 24 (2001) 1359-1364
34. Moran A., Jacobs Jr. D.R., Steinberger J., Hong C.P., Prineas R., Luepker R., et al. Insulin resistance during puberty: results from clamp studies in 357 children. Diabetes 48 (1999) 2039-2044
35. Travers S.H., Jeffers B.W., Bloch C.A., Hill J.O., and Eckel R.H. Gender and Tanner stage differences in body composition and insulin sensitivity in early pubertal children. J Clin Endocrinol Metab 80 (1995) 172-178
36. Ehtisham S., Crabtree N., Clark P., Shaw N., and Barrett T. Ethnic differences in insulin resistance and body composition in United Kingdom adolescents. J Clin Endocrinol Metab 90 (2005) 3963-3969
37. Centers for Disease Control and Prevention (CDC). National diabetes fact sheet: general information and national estimates on diabetes in the United States (2005), US Department of Health and Human Services, CDC, Atlanta
38. Bruns C.M., and Kemnitz J.W. Sex hormones, insulin sensitivity, and diabetes mellitus. ILAR J 45 (2004) 160-169
39. Sarafidis P.A., McFarlane S.I., and Bakris G.L. Gender disparity in outcomes of care and management for diabetes and the metabolic syndrome. Curr Diab Rep 6 (2006) 219-224
40. Kannel W.B., Hjortland M., and Castelli W.P. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 34 (1974) 29-34
41. Billimoria F.R., Katyare S.S., and Patel S.P. Insulin status differentially affects energy transduction in cardiac mitochondria from male and female rats. Diabetes Obes Metab 8 (2006) 67-74
42. Malorni W., Campesi I., Straface E., Vella S., and Franconi F. Redox features of the cell: a gender perspective. Antioxid Redox Signal 9 (2007) 1779-1802
43. Marra G., Cotroneo P., Pitocco D., Manto A., Di Leo M.A.S., Ruotolo V., et al. Early increase of oxidative stress and reduced antioxidant defenses in patients with uncomplicated type 1 diabetes: a case for gender difference. Diabetes Care 25 (2002) 370-375
44. Chevalier S., Marliss E.B., Morais J.A., Lamarche M., and Gougeon R. The influence of sex on the protein anabolic response to insulin. Metabolism 54 (2005) 1529-1535
45. Amiel S.A., Caprio S., Sherwin R.S., Plewe G., Haymond M.W., and Tamborlane W.V. Insulin resistance of puberty: a defect restricted to peripheral glucose metabolism. J Clin Endocrinol Metab 72 (1991) 277-282
46. Smith C.P., Dunger D.B., Williams A.J., Taylor A.M., Perry L.A., Gale E.A., et al. Relationship between insulin, insulin-like growth factor I, and dehydroepiandrosterone sulfate concentrations during childhood, puberty, and adult life. J Clin Endocrinol Metab 68 (1989) 932-937
47. Caprio S., Plewe G., Diamond M.P., Simonson D.C., Boulware S.D., Sherwin R.S., et al. Increased insulin secretion in puberty: a compensatory response to reductions in insulin sensitivity. J Pediatr 114 (1989) 963-967
48. Bloch C.A., Clemons P., and Sperling M.A. Puberty decreases insulin sensitivity. J Pediatr 110 (1987) 481-487
49. Lunt H. Women and diabetes. Diabet Med 13 (1996) 1009-1016
50. Escalante Pulido J.M., and Alpizar Salazar M. Changes in insulin sensitivity, secretion and glucose effectiveness during menstrual cycle. Arch Med Res 30 (1999) 19-22
51. Diamond M.P., Simonson D.C., and DeFronzo R.A. Menstrual cyclicity has a profound effect on glucose homeostasis. Fertil Steril 52 (1989) 204-208
52. Kaaja R.J., and Poyhonen-Alho M.K. Insulin resistance and sympathetic overactivity in women. J Hypertens 24 (2006) 131-141
53. Bertoli A., De Pirro R., Fusco A., Greco A.V., Magnatta R., and Lauro R. Differences in insulin receptors between men and menstruating women and influence of sex hormones on insulin binding during the menstrual cycle. J Clin Endocrinol Metab 50 (1980) 246-250
54. Pedersen O., Hjollund E., and Lindskov H.O. Insulin binding and action on fat cells from young healthy females and males. Am J Physiol 243 (1982) E158-E167
55. Kanaya A.M., Herrington D., Vittinghoff E., Lin F., Grady D., Bittner V., et al. Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/Progestin Replacement Study. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 138 (2003) 1-9
56. Margolis K.L., Bonds D.E., Rodabough R.J., Tinker L., Phillips L.S., Allen C., et al. Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial. Diabetologia 47 (2004) 1175-1187
57. Petersen K.R., Skouby S.O., Sidelmann J., Molsted-Pedersen L., and Jespersen J. Effects of contraceptive steroids on cardiovascular risk factors in women with insulin-dependent diabetes mellitus. Am J Obstet Gynecol 171 (1994) 400-405
58. Polderman K.H., Gooren L.J., Asscheman H., Bakker A., and Heine R.J. Induction of insulin resistance by androgens and estrogens. J Clin Endocrinol Metab 79 (1994) 265-271
59. Perseghin G., Scifo P., Pagliato E., Battezzati A., Benedini S., Soldini L., et al. Gender factors affect fatty acids-induced insulin resistance in nonobese humans: effects of oral steroidal contraception. J Clin Endocrinol Metab 86 (2001) 3188-3196
60. Jones M.E., Thorburn A.W., Britt K.L., Hewitt K.N., Wreford N.G., Proietto J., et al. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci USA 97 (2000) 12735-12740
61. Takeda K., Toda K., Saibara T., Nakagawa M., Saika K., Onishi T., et al. Progressive development of insulin resistance phenotype in male mice with complete aromatase (CYP19) deficiency. J Endocrinol 176 (2003) 237-246
62. Faustini-Fustini M., Rochira V., and Carani C. Oestrogen deficiency in men: where are we today?. Eur J Endocrinol 140 (1999) 111-129
63. Tok E.C., Ertunc D., Evruke C., and Dilek S. The androgenic profile of women with non-insulin-dependent diabetes mellitus. J Reprod Med 49 (2004) 746-752
64. Toprak S., Yonem A., Cakir B., Guler S., Azal O., Ozata M., et al. Insulin resistance in nonobese patients with polycystic ovary syndrome. Horm Res 55 (2001) 65-70
65. Kalish G.M., Barrett-Connor E., Laughlin G.A., and Gulanski B.I. Association of endogenous sex hormones and insulin resistance among postmenopausal women: results from the Postmenopausal Estrogen/Progestin Intervention Trial. J Clin Endocrinol Metab 88 (2003) 1646-1652
66. Oh J.Y., Barrett-Connor E., Wedick N.M., and Wingard D.L. Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study. Diabetes Care 25 (2002) 55-60
67. Haffner S.M., Karhapaa P., Mykkanen L., and Laakso M. Insulin resistance, body fat distribution, and sex hormones in men. Diabetes 43 (1994) 212-219
68. Sowers M., Derby C., Jannausch M.L., Torrens J.I., and Pasternak R. Insulin resistance, hemostatic factors, and hormone interactions in pre- and perimenopausal women: SWAN. J Clin Endocrinol Metab 88 (2003) 4904-4910
69. Haffner S.M. The insulin resistance syndrome revisited. Diabetes Care 19 (1996) 275-277
70. Christodoulakos G., Lambrinoudaki I., Panoulis C., Sioulas V., Rizos D., Caramalis G., et al. Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene. Maturitas 50 (2005) 321-330
71. Buffington C.K., Givens J.R., and Kitabchi A.E. Opposing actions of dehydroepiandrosterone and testosterone on insulin sensitivity. In vivo and in vitro studies of hyperandrogenic females. Diabetes 40 (1991) 693-700
72. Simon D., Preziosi P., Barrett-Connor E., Roger M., Saint-Paul M., Nahoul K., et al. Interrelation between plasma testosterone and plasma insulin in healthy adult men: the Telecom Study. Diabetologia 35 (1992) 173-177
73. Hautanen A., and Adlercreutz H. Hyperinsulinaemia, dyslipidaemia and exaggerated adrenal androgen response to adrenocorticotropin in male smokers. Diabetologia 36 (1993) 1275-1281
74. Okubo M., Tokui M., Egusa G., and Yamakido M. Association of sex hormone-binding globulin and insulin resistance among Japanese-American subjects. Diabetes Res Clin Pract 47 (2000) 71-75
75. Stellato R.K., Feldman H.A., Hamdy O., Horton E.S., and McKinlay J.B. Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care 23 (2000) 490-494
76. Korhonen S., Hippelainen M., Niskanen L., Vanhala M., and Saarikoski S. Relationship of the metabolic syndrome and obesity to polycystic ovary syndrome: a controlled, population-based study. Am J Obstet Gynecol 184 (2001) 289-296
77. Laaksonen D.E., Niskanen L., Punnonen K., Nyyssonen K., Tuomainen T.P., Valkonen V.P., et al. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle aged men. Diabetes Care 27 (2004) 1036-1041
78. Muller M., Grobbee D.E., den Tonkelaar I., Lamberts S.W.J., and van der Schouw Y.T. Endogenous sex hormones and metabolic syndrome in aging men. J Clin Endocrinol Metab 90 (2005) 2618-2623
79. Golden S.H., Ding J., Szklo M., Schmidt M.I., Duncan B.B., and Dobs A. Glucose and insulin components of the metabolic syndrome are associated with hyperandrogenism in postmenopausal women: the atherosclerosis risk in communities study. Am J Epidemiol 160 (2004) 540-548
80. Andersson B., Marin P., Lissner L., Vermeulen A., and Bjorntorp P. Testosterone concentrations in women and men with NIDDM. Diabetes Care 17 (1994) 405-411
81. Pasquali R., Casimirri F., Cantobelli S., Melchionda N., Labate A.M.M., Fabbri R., et al. Effect of obesity and body fat distribution on sex hormones and insulin in men. Metabolism 40 (1991) 101-104
82. Simon D., Charles M.A., Lahlou N., Nahoul K., Oppert J.M., Gouault-Heilmann M., et al. Androgen therapy improves insulin sensitivity and decreases leptin level in healthy adult men with low plasma total testosterone: a 3-month randomized placebo-controlled trial. Diabetes Care 24 (2001) 2149-2151
83. Pitteloud N., Mootha V.K., Dwyer A.A., Hardin M., Lee H., Eriksson K.F., et al. Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men. Diabetes Care 28 (2005) 1636-1642
84. Ding E.L., Song Y., Malik V.S., and Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 295 (2006) 1288-1299
85. Snyder P.J., Peachey H., Hannoush P., Berlin J.A., Loh L., Lenrow D.A., et al. Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J Clin Endocrinol Metab 84 (1999) 2647-2653
86. Rebuffe-Scrive M., Marin P., and Bjorntorp P. Effect of testosterone on abdominal adipose tissue in men. Int J Obes 15 (1991) 791-795
87. Marin P. Testosterone and regional fat distribution. Obes Res 3 (1995) 609S-612S
88. Lovejoy J.C., Bray G.A., Bourgeois M.O., Macchiavelli R., Rood J.C., Greeson C., et al. Exogenous androgens influence body composition and regional body fat distribution in obese postmenopausal women-a clinical research center study. J Clin Endocrinol Metab 81 (1996) 2198-2203
89. Gambineri A., Pagotto U., Tschop M., Vicennati V., Manicardi E., Carcello A., et al. Anti-androgen treatment increases circulating ghrelin levels in obese women with polycystic ovary syndrome. J Endocrinol Invest 26 (2003) 629-634
90. Vierhapper H., Nowotny P., and Waldhausl W. Sex-specific differences in cortisol production rates in humans. Metabolism 47 (1998) 974-976
91. Kudielka B.M., and Kirschbaum C. Sex differences in HPA axis responses to stress: a review. Biol Psychol 69 (2005) 113-132
92. Otte C., Hart S., Neylan T.C., Marmar C.R., Yaffe K., and Mohr D.C. A meta-analysis of cortisol response to challenge in human aging: importance of gender. Psychoneuroendocrinology 30 (2005) 80-91
93. Willis T. Pharmaceutice rationalis: or the exercitation of the operation of medicines in humane bodies. The works of Thomas Willis (1679), Dring, Harper, & Leigh, London
94. Maudsley H. The pathology of mind (1899), Appleton, New York
95. Bjorntorp P. Neuroendocrine perturbations as a cause of insulin resistance. Diabetes Metab Res Rev 15 (1999) 427-441
96. Rosmond R. Stress induced disturbances of the HPA axis: a pathway to Type 2 diabetes?. Med Sci Monit 9 (2003) RA35-RA39
97. Kaplan J.R., Adams M.R., Clarkson T.B., Manuck S.B., Shively C.A., and Williams J.K. Psychosocial factors, sex differences, and atherosclerosis: lessons from animal models. Psychosom Med 58 (1996) 598-611
98. Genuth S.M. The adrenal glands. In: Berne R., and Levy M.N. (Eds). Physiology (1998), Mosby, St. Louis, MO 930-964
99. Chrousos G.P. The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-related causes. Int J Obes Relat Metab Disord 24 Suppl 2 (2000) S50-S55
100. Catargi B., Rigalleau V., Poussin A., Ronci-Chaix N., Bex V., Vergnot V., et al. Occult Cushing's syndrome in type-2 diabetes. J Clin Endocrinol Metab 88 (2003) 5808-5813
101. Holt R.I., Simpson H.L., and Sonksen P.H. The role of the growth hormone-insulin-like growth factor axis in glucose homeostasis. Diabetes Med 20 (2003) 3-15
102. Meinhardt U.J., and Ho K.K. Modulation of growth hormone action by sex steroids. Clin Endocrinol (Oxf) 65 (2006) 413-422
103. Knol M.J., Twisk J.W.R., Beekman A.T.F., Heine R.J., Snoek F.J., and Pouwer F. Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia 49 (2006) 837-845
104. Musselman D.L., Betan E., Larsen H., and Phillips L.S. Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry 54 (2003) 317-329
105. Talbot F., and Nouwen A. A review of the relationship between depression and diabetes in adults: is there a link?. Diabetes Care 23 (2000) 1556-1562
106. Bjorntorp P. Do stress reactions cause abdominal obesity and comorbidities?. Obes Rev 2 (2001) 73-86
107. Ramasubbu R. Insulin resistance: a metabolic link between depressive disorder and atherosclerotic vascular diseases. Med Hypotheses 59 (2002) 537-551
108. Weber-Hamann B., Hentschel F., Kniest A., Deuschle M., Colla M., Lederbogen F., et al. Hypercortisolemic depression is associated with increased intra-abdominal fat. Psychosom Med 64 (2002) 274-277
109. Murray C.J., and Lopez A.D. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 349 (1997) 1498-1504
110. Seeley R.J., and Woods S.C. Monitoring of stored and available fuel by the CNS: implications for obesity. Nat Rev Neurosci 4 (2003) 901-909
111. Schwartz M.W., and Porte Jr. D. Diabetes, obesity, and the brain. Science 307 (2005) 375-379
112. Obici S., Feng Z., Karkanias G., Baskin D.G., and Rossetti L. Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats. Nat Neurosci 5 (2002) 566-572
113. Flanagan D.E., Vaile J.C., Petley G.W., Phillips D.I., Godsland I.F., Owens P., et al. Gender differences in the relationship between leptin, insulin resistance and the autonomic nervous system. Regul Pept 140 (2007) 37-42
114. Facchini F.S., Stoohs R.A., and Reaven G.M. Enhanced sympathetic nervous system activity. The linchpin between insulin resistance, hyperinsulinemia, and heart rate. Am J Hypertens 9 (1996) 1013-1017
115. Lillioja S., Mott D.M., Spraul M., Ferraro R., Foley J.E., Ravussin E., et al. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 329 (1993) 1988-1992
116. Plum L., Wunderlich F.T., Baudler S., Krone W., and Bruning J.C. Transgenic and knockout mice in diabetes research: novel insights into pathophysiology, limitations, and perspectives. Physiology (Bethesda) 20 (2005) 152-161
117. Froguel P., Velho G., Passa P., and Cohen D. Genetic determinants of type 2 diabetes mellitus: lessons learned from family studies. Diabetes Metab 19 (1993) 1-10
118. Thorburn A.W., Holdsworth A., Proietto J., and Morahan G. Differential and genetically separable associations of leptin with obesity-related traits. Int J Obes 24 (2000) 742-750
119. Kim J.H., Sen S., Avery C.S., Simpson E., Chandler P., Nishina P.M., et al. Genetic analysis of a new mouse model for non-insulin-dependent diabetes. Genomics 74 (2001) 273-286
120. Leiter E.H. Control of spontaneous glucose intolerance, hyperinsulinemia, and islet hyperplasia in nonobese C3H.SW male mice by Y-linked locus and adrenal gland. Metabolism 37 (1988) 689-696
121. Figueroa C.D., and Taberner P.V. Pancreatic islet hypertrophy in spontaneous maturity onset obese-diabetic CBA/Ca mice. Int J Biochem 26 (1994) 1299-1303
122. Tirabassi R.S., Flanagan J.F., Wu T., Kislauskis E.H., Birckbichler P.J., and Guberski D.L. The BBZDR/Wor rat model for investigating the complications of type 2 diabetes mellitus. ILAR J 45 (2004) 292-302
123. Peterson R.G., Shaw W.N., Neel M.A., Little L.A., Kincaid J.C., and Eichberg J. Zucker diabetic fatty rat as a model for non-insulin-dependent diabetes mellitus. ILAR News 32 (1990) 16-19
124. Wang Z., Moro E., Kovacs K., Yu R., and Melmed S. Pituitary tumor transforming gene-null male mice exhibit impaired pancreatic beta cell proliferation and diabetes. Proc Natl Acad Sci USA 100 (2003) 3428-3432
125. Fraenkel M., Caloyeras J., Ren S.G., and Melmed S. Sex-steroid milieu determines diabetes rescue in PTTG-null mice. J Endocrinol 189 (2006) 519-528
126. Song D., Arikawa E., Galipeau D., Battell M., and McNeill J.H. Androgens are necessary for the development of fructose-induced hypertension. Hypertension 43 (2004) 667-672
127. Accili D., Drago J., Lee E.J., Johnson M.D., Cool M.H., Salvatore P., et al. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nat Genet 12 (1996) 106-109
128. Kido Y., Burks D.J., Withers D., Bruning J.C., Kahn C.R., White M.F., et al. Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2. J Clin Invest 105 (2000) 199-205
129. Thomas M.K., Devon O.N., Lee J.H., Peter A., Schlosser D.A., Tenser M.S., et al. Development of diabetes mellitus in aging transgenic mice following suppression of pancreatic homeoprotein IDX-1. J Clin Invest 108 (2001) 319-329
130. Ostenson C.G., Grill V., and Roos M. Studies on sex dependency of B-cell susceptibility to streptozotocin in a rat model of type II diabetes mellitus. Exp Clin Endocrinol 93 (1989) 241-247
131. Bell R.C., Khurana M., Ryan E.A., and Finegood D.T. Gender differences in the metabolic response to graded numbers of transplanted islets of Langerhans. Endocrinology 135 (1994) 2681-2687
132. Vital P., Larrieta E., and Hiriart M. Sexual dimorphism in insulin sensitivity and susceptibility to develop diabetes in rats. J Endocrinol 190 (2006) 425-432
133. Ohno T., Yoshida F., Ichikawa Y., Matsuo S., Hotta N., Terada M., et al. A new spontaneous animal model of NIDDM without obesity in the musk shrew. Life Sci 62 (1998) 995-1006
134. Richter M., Guscetti F., and Spiess B. Aldose reductase activity and glucose-related opacities in incubated lenses from dogs and cats. Am J Vet Res 63 (2002) 1591-1597
135. Salgado D., Reusch C., and Spiess B. Diabetic cataracts: different incidence between dogs and cats. Schweiz Arch Tierheilkd 142 (2000) 349-353
136. Baral R., Rand J., Catt M., and Farrow H. Prevalence of feline diabetes mellitus in a feline private practice. J Vet Int Med 17 (2003) 433-444
137. Rand J.S., Bobbermien L.M., Hendrikz J.K., and Copland M. Over representation of Burmese cats with diabetes mellitus. Aust Vet J 75 (1997) 402-405
138. Hoenig M., Hall G., Ferguson D., Jordan K., Henson M., Johnson K., et al. A feline model of experimentally induced islet amyloidosis. Am J Pathol 157 (2000) 2143-2150
139. Larsen M.O., and Rolin B. Use of the Gottingen minipig as a model of diabetes, with special focus on type 1 diabetes research. ILAR J 45 (2004) 303-313
140. Brodala N., Merricks E.P., Bellinger D.A., Damrongsri D., Offenbacher S., Beck J., et al. Porphyromonas gingivalis bacteremia induces coronary and aortic atherosclerosis in normocholesterolemic and hypercholesterolemic pigs. Arterioscler Thromb Vasc Biol 25 (2005) 1451-1456
141. Gerrity R.G., Naito H.K., Richardson M., and Schwartz C.J. Dietary induced atherogenesis in swine: morphology of the intima in prelesion stages. Am J Pathol 95 (1979) 775-792
142. Nichols T.C., Bellinger D.A., Davis K.E., Koch G.G., Reddick R.L., Read M.S., et al. Porcine von Willebrand disease and atherosclerosis. Influence of polymorphism in apolipoprotein B100 genotype. Am J Pathol 140 (1992) 403-415
143. Prescott M., McBride C., Hasler-Rapacz J., Von Linden J., and Rapacz J. Development of complex atherosclerotic lesions in pigs with inherited hyper-LDL cholesterolemia bearing mutant alleles for apolipoprotein B. Am J Pathol 139 (1991) 139-147
144. Prescott M.F., Hasler-Rapacz J., von Linden-Reed J., and Rapacz J. Familial hypercholesterolemia associated with coronary atherosclerosis in swine bearing different alleles for apolipoprotein B. Ann NY Acad Sci 748 (1995) 283-292
145. Hasler-Rapacz J., Kempen H.J., Princen H.M., Kudchodkar B.J., Lacko A., and Rapacz J. Effects of simvastatin on plasma lipids and apolipoproteins in familial hypercholesterolemic swine. Arterioscler Thromb Vasc Biol 16 (1996) 137-143
146. Johnson G.J., Griggs T.R., and Badimon L. The utility of animal models in the preclinical study of interventions to prevent human coronary artery restenosis: analysis and recommendations. On behalf of the Subcommittee on Animal, Cellular and Molecular Models of Thrombosis and Haemostasis of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 81 (1999) 835-843
147. Dixon J.L., Stoops J.D., Parker J.L., Laughlin M.H., Weisman G.A., and Sturek M. Dyslipidemia and vascular dysfunction in diabetic pigs fed an atherogenic diet. Arterioscler Thromb Vasc Biol 19 (1999) 2981-2992
148. Caixas A., Ordonez-Llanos J., de Leiva A., Payes A., Homs R., and Perez A. Optimization of glycemic control by insulin therapy decreases the proportion of small dense LDL particles in diabetic patients. Diabetes 46 (1997) 1207-1213
149. Larsen M.O., Rolin B., Wilken M., Carr R.D., Svendsen O., and Bollen P. Parameters of glucose and lipid metabolism in the male Gottingen minipig: influence of age, body weight, and breeding family. Comp Med 51 (2001) 436-442
150. Johansen T., Hansen H.S., Richelsen B., and Malmlof R. The obese Gottingen minipig as a model of the metabolic syndrome: dietary effects on obesity, insulin sensitivity, and growth hormone profile. Comp Med 51 (2001) 150-155
151. Dyson M.C., Alloosh M., Vuchetich J.P., Mokelke E.A., and Sturek M. Components of metabolic syndrome and coronary artery disease in female Ossabaw swine fed excess atherogenic diet. Comp Med 56 (2006) 35-45
152. Mattern H.M., Lloyd P.G., Sturek M., and Hardin C.D. Gender and genetic differences in bladder smooth muscle PPAR mRNA in a porcine model of the metabolic syndrome. Mol Cell Biochem 302 (2007) 43-49
153. Kim C., Newton K.M., and Knopp R.H. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 25 (2002) 1862-1868
154. Weyer C., Bogardus C., Mott D.M., and Pratley R.E. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104 (1999) 787-794
155. Ramsey J.J., Laatsch J.L., and Kemnitz J.W. Age and gender differences in body composition, energy expenditure, and glucoregulation of adult rhesus monkeys. J Med Primatol 29 (2000) 11-19
156. Kavanagh K., Koudy Williams J., and Wagner J.D. Naturally occurring menopause in cynomolgus monkeys: changes in hormone, lipid, and carbohydrate measures with hormonal status. J Med Primatol 34 (2005) 171-177
157. Wagner J.D., Cline J.M., Shadoan M.K., Bullock B.C., Rankin S.E., and Cefalu W.T. Naturally occurring and experimental diabetes in cynomolgus monkeys: a comparison of carbohydrate and lipid metabolism and islet pathology. Toxicol Pathol 29 (2001) 142-148
158. Gale E.A., and Gillespie K.M. Diabetes and gender. Diabetologia 44 (2001) 3-15
159. Ozanne S.E., and Hales C.N. The long-term consequences of intra-uterine protein malnutrition for glucose metabolism. Proc Nutr S 58 (1999) 615-619
160. Hales C., and Barker D. The thrifty phenotype hypothesis. Br Med Bull 60 (2001) 5-20
161. Flanagan D.E., Moore V.M., Godsland I.F., Cockington R.A., Robinson J.S., and Phillips D.I. Fetal growth and the physiological control of glucose tolerance in adults: a minimal model analysis. Am Physiol Endocrinol Metab 278 (2000) E700-E706
162. Ozanne S., Smith G., Tikerpae J., and Hales C. Altered regulation of hepatic glucose output in the male offspring of protein-malnourished rat dams. Am J Physiol 270 (1996) E559-E564
163. Holemans K., Aerts L., and Van Assche F.A. Evidence for an insulin resistance in the adult offspring of pregnant streptozotocin-diabetic rats. Diabetologia 34 (1991) 81-85
164. Simmons R.A., Templeton L.J., and Gertz S.J. Intrauterine growth retardation leads to the development of type 2 diabetes in the rat. Diabetes 50 (2001) 2279-2286
165. Loizzo A, Carta S, Bennardini F, Coinu R, Loizzo S, Guarino I, et al. Neonatal taurine administration modifies metabolic programming in male mice. Early Hum Dev; 2007 Epub.
166. Petry C.J., Dorling M.W., Pawlak D.B., Ozanne S.E., and Hales C.N. Diabetes in old male offspring of rat dams fed a reduced protein diet. Int J Exp Diabetes Res 2 (2001) 139-143
167. Lane R.H., Kelley D.E., Gruetzmacher E.M., and Devaskar S.U. Uteroplacental insufficiency alters hepatic fatty acid-metabolizing enzymes in juvenile and adult rats. Am J Physiol Regul Integr Comp Physiol 280 (2001) R183-R190
168. Lane R.H., Maclennan N.K., Daood M.J., Hsu J.L., Janke S.M., Pham T.D., et al. IUGR alters postnatal rat skeletal muscle peroxisome proliferator-activated receptor-gamma coactivator-1 gene expression in a fiber specific manner. Pediatr Res 53 (2003) 994-1000
169. Sugden M.C., and Holness M.J. Gender-specific programming of insulin secretion and action. J Endocrinol 175 (2002) 757-767
170. Desai M., Crowther N.J., Lucas A., and Hales C.N. Organ-selective growth in the offspring of protein-restricted mothers. Br J Nutr 76 (1996) 591-603
171. Merzouk H., Madani S., Chabane Sari D., Prost J., Bouchenak M., and Belleville J. Time course of changes in serum glucose, insulin, lipids and tissue lipase activities in macrosomic offspring of rats with streptozotocin-induced diabetes. Clin Sci 98 (2000) 21-30
172. Gelardi N.L., Cha C.J., and Oh W. Glucose metabolism in adipocytes of obese offspring of mild hyperglycemic rats. Pediatr Res 28 (1990) 641-645
173. Gelardi N.L., Cha C.J., and Oh W. Evaluation of insulin sensitivity in obese offspring of diabetic rats by hyperinsulinemic-euglycemic clamp technique. Pediatr Res 30 (1991) 40-44
174. Park H.K., Jin C.J., Cho Y.M., Park D.J., Shin C.S., Park K.S., et al. Changes of mitochondrial DNA content in the male offspring of protein-malnourished rats. Ann NY Acad Sci 1011 (2004) 205-216
175. Seghieri G., Anichini R., De Bellis A., Alviggi L., Franconi F., and Breschi M.C. Relationship between gestational diabetes mellitus and low maternal birth weight. Diabetes Care 25 (2002) 1761-1765
176. Fetita L.S., Sobngwi E., Serradas P., Calvo F., and Gautier J.F. Consequences of fetal exposure to maternal diabetes in offspring. Clin Endocrinol Metab 91 (2006) 3718-3724
177. Holemans K., and Aerts K. Lessons from experimental research: lasting consequences of fetal development in an abnormal intra-uterine milieu. In: Van Assche F. (Ed). Diabetes and pregnancy (2004), Elsevier, UK 123-141
178. Galietta G., Loizzo A., Loizzo S., Trombetta G., Spampinato S., Campana G., et al. Administration of antisense oligonucleotide against pro-opiomelanocortin prevents enduring hormonal alterations induced by neonatal handling in male mice. Eur J Pharmacol 550 (2006) 180-185
179. Rossini A.A., Williams R.M., Appel M.C., and Like A.A. Sex differences in the multiple-dose streptozotocin model of diabetes. Endocrinology 103 (1978) 1518-1520
180. Paik S.G., Michelis M.A., Kim Y.T., and Shin S. Induction of insulin-dependent diabetes by streptozotocin. Inhibition by estrogens and potentiation by androgens. Diabetes 31 (1982) 724-729
181. Kava R.A., West D.B., Lukasik V.A., and Greenwood M.R. Sexual dimorphism of hyperglycemia and glucose tolerance in Wistar fatty rats. Diabetes 38 (1989) 159-163
182. Leiter E.H. The genetics of diabetes susceptibility in mice. FASEB J 3 (1989) 2231-2241
183. Efrat S. Sexual dimorphism of pancreatic beta-cell degeneration in transgenic mice expressing an insulin-ras hybrid gene. Endocrinology 128 (1991) 897-901
184. Shi K., Mizuno A., Sano T., Ishida K., and Shima K. Sexual difference in the incidence of diabetes mellitus in Otsuka-Long-Evans-Tokushima-Fatty rats: effects of castration and sex hormone replacement on its incidence. Metabolism 43 (1994) 1214-1220
185. Geisler J.G., Zawalich W., Zawalich K., Lakey J.R., Stukenbrok H., Milici A.J., et al. Estrogen can prevent or reverse obesity and diabetes in mice expressing human islet amyloid polypeptide. Diabetes 51 (2002) 2158-2169
186. Li F.X., Zhu J.W., Tessem J.S., Beilke J., Varella-Garcia M., Jensen J., et al. The development of diabetes in E2f1/E2f2 mutant mice reveals important roles for bone marrow-derived cells in preventing islet cell loss. Proc Natl Acad Sci USA 100 (2003) 12935-12940
187. Iglesias A., Murga M., Laresgoiti U., Skoudy A., Bernales I., Fullaondo A., et al. Diabetes and exocrine pancreatic insufficiency in E2F1/E2F2 double-mutant mice. J Clin Invest 113 (2004) 1398-1407
188. Leiter E.H. The influence of genetic background on the expression of mutations at the diabetes locus in the mouse IV. Male lethal syndrome in CBA/Lt mice. Diabetes 30 (1981) 1035-1044
189. Leiter E.H., Chapman H.D., and Coleman D.L. The influence of genetic background on the expression of mutations at the diabetes locus in the mouse. V. Interaction between the db gene and hepatic sex steroid sulfotransferases correlates with gender-dependent susceptibility to hyperglycemia. Endocrinology 124 (1989) 912-922
190. Kava R.A., West D.B., Lukasik V.A., Wypijewski C., Wojnar Z., Johnson P.R., et al. The effects of gonadectomy on glucose tolerance of genetically obese (fa/fa) rats: influence of sex and genetic background. Int J Obes Relat Metab Disord 16 (1992) 103-111
191. Maclaren N.K., Neufeld M., McLaughlin J.V., and Taylor G. Androgen sensitization of streptozotocin-induced diabetes in mice. Diabetes 29 (1980) 710-716
192. Heine P.A., Taylor J.A., Iwamoto G.A., Lubahn D.B., and Cooke P.S. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci 97 (2000) 12729-12734
193. Bailey C.J., and Ahmed-Sorour H. Role of ovarian hormones in the long-term control of glucose homeostasis. Effects of insulin secretion. Diabetologia 19 (1980) 475-481
194. Puah J.A., and Bailey C.J. Insulinotropic effect of ovarian steroid hormones in streptozotocin diabetic female mice. Horm Metab Res 17 (1985) 216-218
195. Straface E., Rivabene R., Masella R., Santulli M., Paganelli R., and Malorni W. Structural changes of the erythrocyte as a marker of non-insulin-dependent diabetes: protective effects of N-acetylcysteine. Biochem Biophys Res Commun 290 (2002) 1393-1398
196. DeFronzo R.A. Pathogenesis of type 2 diabetes mellitus. Med Clin N Am 88 (2004) 787-835 ix
197. Reaven G.M. The insulin resistance syndrome: definition and dietary approaches to treatment. Annu Rev Nutr 25 (2005) 391-406
198. Unwin N., Shaw J., Zimmet P., and Alberti K.G. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabetes Med 19 (2002) 708-723
199. Kohen-Avramoglu R., Theriault A., and Adeli K. Emergence of the metabolic syndrome in childhood: an epidemiological overview and mechanistic link to dyslipidemia. Clin Biochem 36 (2003) 413-420
200. Hsueh W., Abel E.D., Breslow J.L., Maeda N., Davis R.C., Fisher E.A., et al. Recipes for creating animal models of diabetic cardiovascular disease. Circ Res 100 (2007) 1415-1427
201. Wu K.K., and Huan Y. Diabetic atherosclerosis mouse models. Atherosclerosis 191 (2007) 241-249
202. Degen G.H., Janning P., Diel P., and Bolt H.M. Estrogenic isoflavones in rodent diets. Toxicol Lett 128 (2002) 145-157
203. FDA. www.fda.gov/medwatch/safety/2007/Actosmar0807.pdf; September 3, 2007.
204. Franconi F., Brunelleschi S., Steardo L., and Cuomo V. Gender differences in drug responses. Pharmacol Res 55 (2007) 81-95
205. Franconi F., Carru C., Canu S., and Seghieri G. Targeting gender difference in the introduction of new drugs for diabetes mellitus and metabolic disorders. Recent patents on endocrine. Metab Immune Drug Discov 1 (2007) 152
206. Hasty A.H., Shimano H., Osuga J., Namatame I., Takahashi A., Yahagi N., et al. Severe hypercholesterolemia, hypertriglyceridemia, and atherosclerosis in mice lacking both leptin and the low density lipoprotein receptor. J Biol Chem 276 (2001) 37402-37408
207. Zhang S.H., Reddick R.L., Piedrahita J.A., and Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258 (1992) 468-471
208. Zimmet P., Alberti K.G., and Shaw J. Global and societal implications of the diabetes epidemic. Nature 414 (2001) 782-787
209. Ratcliffe H.L., and Luginbuhl H. The domestic pig: a model for experimental atherosclerosis. Atherosclerosis 13 (1971) 133-136
210. Schrijvers B.F., De Vriese A.S., Van de Voorde J., Rasch R., Lameire N.H., and Flyvbjerg A. Long-term renal changes in the Goto-Kakizaki rat, a model of lean type 2 diabetes. Nephrol Dial Transplant 19 (2004) 1092-1097
211. Shinohara M., Masuyama T., Shoda T., Takahashi T., Katsuda Y., Komeda K., et al. A new spontaneously diabetic non-obese Torii rat strain with severe ocular complications. Int J Exp Diabetes Res 1 (2000) 89-100
212. Butler A.E., Jang J., Gurlo T., Carty M.D., Soeller W.C., and Butler P.C. Diabetes due to a progressive defect in beta-cell mass in rats transgenic for human islet amyloid polypeptide (HIP Rat): a new model for type 2 diabetes. Diabetes 53 (2004) 1509-1516
213. Ortlepp J.R., Kluge R., Giesen K., Plum L., Radke P., Hanrath P., et al. A metabolic syndrome of hypertension, hyperinsulinaemia and hypercholesterolaemia in the New Zealand obese mouse. Eur J Clin Invest 30 (2000) 195-202
214. Leiter E.H., and Reifsnyder P.C. Differential levels of diabetogenic stress in two new mouse models of obesity and type 2 diabetes. Diabetes 53 (2004) S4-S11
215. Kulkarni R.N., Jhala U.S., Winnay J.N., Krajewski S., Montminy M., and Kahn C.R. PDX-1 haploinsufficiency limits the compensatory islet hyperplasia that occurs in response to insulin resistance. J Clin Invest 114 (2004) 828-836
216. Withers D.J., Gutierrez J.S., Towery H., Burks D.J., Ren J.M., Previs S., et al. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391 (1998) 900-904
217. Kubota N., Tobe K., Terauchi Y., Eto K., Yamauchi T., Suzuki R., et al. Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. Diabetes 49 (2000) 1880-1889
218. Masaki T., Chiba S., Noguchi H., Yasuda T., Tobe K., Suzuki R., et al. Obesity in insulin receptor substrate-2-deficient mice: disrupted control of arcuate nucleus neuropeptides. Obes Res 12 (2004) 878-885
219. Kulkarni R.N., and Kahn C.R. Genetic models of insulin resistance: alterations in beta cell biology. Molecular basis of pancreas development and function (2001), Kluwer Academic Publishers, Amsterdam p. 299-323
220. Kulkarni R.N., Winnay J.N., Daniels M., Bruning J.C., Flier S.N., Hanahan D., et al. Altered function of insulin receptor substrate-1-deficient mouse islets and cultured beta-cell lines. J Clin Invest 104 (1999) R69-R75
221. Otani K., Kulkarni R.N., Baldwin A.C., Krutzfeldt J., Ueki K., Stoffel M., et al. Reduced beta-cell mass and altered glucose sensing impair insulin-secretory function in betaIRKO mice. Am J Physiol Endocrinol Metab 286 (2004) E41-E49
222. Michael M.D., Kulkarni R.N., Postic C., Previs S.F., Shulman G.I., Magnuson M.A., et al. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 6 (2000) 87-97
223. Bruning J.C., Gautam D., Burks D.J., Gillette J., Schubert M., Orban P.C., et al. Role of brain insulin receptor in control of body weight and reproduction. Science 289 (2000) 2122-2125
224. Bluher M., Michael M.D., Peroni O.D., Ueki K., Carter N., Kahn B.B., et al. Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev Cell 3 (2002) 25-38
225. Andrikopoulos S., Verchere C.B., Terauchi Y., Kadowaki T., and Kahn S.E. Beta-cell glucokinase deficiency and hyperglycemia are associated with reduced islet amyloid deposition in a mouse model of type 2 diabetes. Diabetes 49 (2000) 2056-2062
226. Grupe A., Hultgren B., Ryan A., Ma Y.H., Bauer M., and Stewart T.A. Transgenic knockouts reveal a critical requirement for pancreatic beta cell glucokinase in maintaining glucose homeostasis. Cell 83 (1995) 69-78
227. Aasum E., Hafstad A.D., Severson D.L., and Larsen T.S. Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice. Diabetes 52 (2003) 434-441
228. Vannucci S.J., Willing L.B., Goto S., Alkayed N.J., Brucklacher R.M., Wood T.L., et al. Experimental stroke in the female diabetic, db/db, mouse. J Cereb Blood Flow Metab 21 (2001) 52-60
229. Klebig M.L., Wilkinson J.E., Geisler J.G., and Woychik R.P. Ectopic expression of the agouti gene in transgenic mice causes obesity, features of type II diabetes, and yellow fur. Proc Natl Acad Sci USA 92 (1995) 4728-4732
230. Ueda H., Ikegami H., Kawaguchi Y., Fujisawa T., Nojima K., Babaya N., et al. Age-dependent changes in phenotypes and candidate gene analysis in a polygenic animal model of type II diabetes mellitus: NSY mouse. Diabetologia 43 (2000) 932-938
231. Ueda H., Ikegami H., Yamato E., Fu J., Fukuda M., Shen G., et al. The NSY mouse: a new animal model of spontaneous NIDDM with moderate obesity. Diabetologia 38 (1995) 503-508
232. Allan M.F., Eisen E.J., and Pomp D. The M16 mouse: an outbred animal model of early onset polygenic obesity and diabesity. Obes Res 12 (2004) 1397-1407
233. Horio F., Teradaira S., Imamura T., Anunciado R.V., Kobayashi M., Namikawa T., et al. The HND mouse, a nonobese model of type 2 diabetes mellitus with impaired insulin secretion. Eur J Endocrinol 153 (2005) 971-979
234. Suzuki W., Iizuka S., Tabuchi M., Funo S., Yanagisawa T., Kimura M., et al. A new mouse model of spontaneous diabetes derived from ddY strain. Exp Anim 48 (1999) 181-189
235. Arulmozhi D.K., Veeranjaneyulu A., and Bodhankar S.L. Neonatal streptozotocin-induced rat model of Type 2 diabetes mellitus: a glance. Indian J Pharmacol 36 (2004) 217-221
236. Lam P.P., Leung Y.M., Sheu L., Ellis J., Tsushima R.G., Osborne L.R., et al. Transgenic mouse overexpressing syntaxin-1A as a diabetes model. Diabetes 54 (2005) 2744-2754
237. Shafrir E., Ziv E., and Kalman R. Nutritionally induced diabetes in desert rodents as models of type 2 diabetes: Acomys cahirinus (spiny mice) and Psammomys obesus (desert gerbil). ILAR J 47 (2006) 212
238. Anunciado R.V., Imamura T., Ohno T., Horio F., and Namikawa T. Developing a new model for non-insulin dependent diabetes mellitus (NIDDM) by using the Philippine wild mouse, Mus musculus castaneus. Exp Anim 49 (2000) 1-8